With less internal volume, ligaments no longer hold skin taut and folds appear around the nose and mouth
March 2024 : The US FDA approved a label expansion for WEGOVY based on a supplemental New Drug Application (sNDA) for the indication of reducing risks of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack (myocardial infarction), or non-fatal stroke in adults with either overweight or obesity and established CVD
Are there any side effects associated with the GLP-1 pill
Joel Lexchin, retired physician and professor emeritus at the school of health policy and management at York University, said data on the drug's long-term effectiveness is too limited
Like, whats the point of continuing to go to the gym, whats the point of continuing to eat healthy, and nothings happening, and I still feel like crap. But her doctor said this new option was different